These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28691689)

  • 21. [Topical treatment with tacrolimus in lupus erythematosus tumidus].
    Bacman D; Tanbajewa A; Megahed M; Ruzicka T; Kuhn A
    Hautarzt; 2003 Oct; 54(10):977-9. PubMed ID: 14513247
    [No Abstract]   [Full Text] [Related]  

  • 22. Lupus erythematosus tumidus in Japan: a case report and a review of the literature.
    Nishiyama M; Kanazawa N; Hiroi A; Furukawa F
    Mod Rheumatol; 2009; 19(5):567-72. PubMed ID: 19562251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced photodistributed rash.
    O'Connor R; Flynn A; Crowther S; Tobin AM; Connolly M
    Clin Exp Dermatol; 2017 Jul; 42(5):590-592. PubMed ID: 28548245
    [No Abstract]   [Full Text] [Related]  

  • 25. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

  • 26. Imiquimod-induced subacute cutaneous lupus erythematosus-like changes.
    Maguiness SM; Farsani TT; Zedek DC; Berger TG
    Cutis; 2015 Jun; 95(6):349-51. PubMed ID: 26125212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly recognized cutaneous drug eruptions.
    Callen JP
    Dermatol Clin; 2007 Apr; 25(2):255-61, viii. PubMed ID: 17430762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
    Wollenberg A; Meurer M
    Hautarzt; 1991 Nov; 42(11):709-12. PubMed ID: 1837545
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Gonzalez CD; Hansen C; Clarke JT
    J Am Acad Dermatol; 2019 Sep; 81(3):859-860. PubMed ID: 31085265
    [No Abstract]   [Full Text] [Related]  

  • 30. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
    Suess A; Sticherling M
    Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manifestations and treatment of cutaneous lupus erythematosus (part I of II).
    Schairer D; Friedman A
    J Drugs Dermatol; 2011 Oct; 10(10):1212-4. PubMed ID: 21968677
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and Lupus erythematosus tumidus.
    Schepis C; Lentini M; Siragusa M; Batolo D
    Dermatology; 2004; 208(4):354-5. PubMed ID: 15178923
    [No Abstract]   [Full Text] [Related]  

  • 34. Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: the enigma of the Rowell syndrome.
    Baroni A; Piccolo V; Russo T; Cozzolino D; Mascolo M; Chessa MA
    J Dtsch Dermatol Ges; 2014 Nov; 12(11):1039-42. PubMed ID: 25382568
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients.
    Aitmehdi R; Arnaud L; Francès C; Senet P; Monfort JB; de Risi-Pugliese T; Barbaud A; Cohen-Aubart F; Haroche J; Pha M; Hie M; Le Guern V; Costedoat-Chalumeau N; Mékinian A; Fain O; Mathian A; Amoura Z; Chasset F
    J Am Acad Dermatol; 2021 Apr; 84(4):1171-1174. PubMed ID: 33221461
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus.
    Parodi A; Rivara G; Guarrera M
    JAMA; 1992 Jul; 268(1):51-2. PubMed ID: 1535107
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicin.
    Chen JK; Chen TS; Lim P; Iqbal M
    J Am Acad Dermatol; 2012 Dec; 67(6):e273-5. PubMed ID: 23158635
    [No Abstract]   [Full Text] [Related]  

  • 38. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dermatitis caused by aldactone of a lupic annular erythema type].
    Leroy D; Dompmartin A; Le Jean S; Guillemain JL; Mandard JC; Deschamps P
    Ann Dermatol Venereol; 1987; 114(10):1237-40. PubMed ID: 2963578
    [No Abstract]   [Full Text] [Related]  

  • 40. Lupus erythematosus with leflunomide: induction or reactivation?
    Gensburger D; Kawashima M; Marotte H; Kanitakis J; Miossec P
    Ann Rheum Dis; 2005 Jan; 64(1):153-5. PubMed ID: 15608317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.